Annual Working Capital
$80.58 M
-$9.88 M-10.92%
31 December 2023
Summary:
Silence Therapeutics annual working capital is currently $80.58 million, with the most recent change of -$9.88 million (-10.92%) on 31 December 2023. During the last 3 years, it has fallen by -$15.47 million (-16.11%). SLN annual working capital is now -16.11% below its all-time high of $96.05 million, reached on 31 December 2021.SLN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$188.15 M
-$12.24 M-6.11%
01 September 2024
Summary:
Silence Therapeutics quarterly working capital is currently $188.15 million, with the most recent change of -$12.24 million (-6.11%) on 01 September 2024. Over the past year, it has increased by +$107.57 million (+133.51%). SLN quarterly working capital is now -11.06% below its all-time high of $211.54 million, reached on 31 March 2024.SLN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +133.5% |
| 3 y3 years | -16.1% | +95.9% |
| 5 y5 years | +121.0% | +416.0% |
SLN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -16.1% | at low | -11.1% | +187.8% |
| 5 y | 5 years | -16.1% | +121.0% | -11.1% | +416.0% |
| alltime | all time | -16.1% | >+9999.0% | -11.1% | >+9999.0% |
Silence Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $188.15 M(-6.1%) |
| June 2024 | - | $200.39 M(-5.3%) |
| Mar 2024 | - | $211.54 M(+162.5%) |
| Dec 2023 | $80.58 M(-10.9%) | $80.58 M(-5.1%) |
| Sept 2023 | - | $84.90 M(+7.3%) |
| June 2023 | - | $79.16 M(-3.0%) |
| Mar 2023 | - | $81.64 M(-9.7%) |
| Dec 2022 | $90.45 M(-5.8%) | $90.45 M(-7.5%) |
| Sept 2022 | - | $97.74 M(+49.5%) |
| June 2022 | - | $65.36 M(-18.7%) |
| Mar 2022 | - | $80.37 M(-16.3%) |
| Dec 2021 | $96.05 M(+38.7%) | $96.05 M(+10.5%) |
| Sept 2021 | - | $86.92 M(-18.0%) |
| June 2021 | - | $105.99 M(+53.0%) |
| Dec 2020 | $69.26 M(+89.9%) | $69.26 M(-30.9%) |
| June 2020 | - | $100.27 M(+175.0%) |
| Dec 2019 | $36.47 M(+12.0%) | - |
| Dec 2019 | - | $36.47 M(+60.8%) |
| June 2019 | - | $22.68 M(-30.4%) |
| Dec 2018 | $32.57 M(-43.8%) | - |
| Dec 2018 | - | $32.57 M(-28.2%) |
| June 2018 | - | $45.39 M(-21.7%) |
| Dec 2017 | $57.96 M(+16.8%) | - |
| Dec 2017 | - | $57.96 M(+46.4%) |
| June 2017 | - | $39.58 M(-20.2%) |
| Dec 2016 | $49.63 M(-36.1%) | - |
| Dec 2016 | - | $49.63 M(-24.2%) |
| June 2016 | - | $65.51 M(-15.7%) |
| Dec 2015 | $77.68 M(+146.8%) | - |
| Dec 2015 | - | $77.68 M(-10.5%) |
| June 2015 | - | $86.83 M(+175.9%) |
| Dec 2014 | $31.47 M(-2.4%) | - |
| Dec 2014 | - | $31.47 M(-27.5%) |
| June 2014 | - | $43.40 M(+34.6%) |
| Dec 2013 | $32.25 M(+146.4%) | - |
| Dec 2013 | - | $32.25 M(-12.4%) |
| June 2013 | - | $36.83 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $13.09 M(+221.9%) | - |
| Dec 2012 | - | $13.09 M(>+9900.0%) |
| June 2012 | - | $127.20 K(-96.9%) |
| Dec 2011 | $4.07 M(-2.1%) | - |
| Dec 2011 | - | $4.07 M(-47.7%) |
| June 2011 | - | $7.77 M(+87.3%) |
| Dec 2010 | $4.15 M(-827.3%) | - |
| Dec 2010 | - | $4.15 M(-40.4%) |
| June 2010 | - | $6.96 M(-1319.9%) |
| Dec 2009 | -$570.80 K(-111.2%) | - |
| Dec 2009 | - | -$570.90 K(-111.7%) |
| June 2009 | - | $4.86 M(-4.7%) |
| Dec 2008 | $5.10 M(-73.9%) | - |
| Dec 2008 | - | $5.10 M(-56.4%) |
| June 2008 | - | $11.70 M(-40.2%) |
| Dec 2007 | $19.55 M(+16.2%) | - |
| Dec 2007 | - | $19.55 M(+76.3%) |
| June 2007 | - | $11.09 M(-34.1%) |
| Dec 2006 | $16.83 M(+17.5%) | - |
| Dec 2006 | - | $16.83 M(+37.9%) |
| June 2006 | - | $12.21 M(-14.7%) |
| Dec 2005 | $14.32 M(+164.0%) | - |
| Dec 2005 | - | $14.32 M(+335.4%) |
| June 2005 | - | $3.29 M(-39.4%) |
| Dec 2004 | $5.42 M(-40.8%) | - |
| Dec 2004 | - | $5.42 M(-10.9%) |
| June 2004 | - | $6.08 M(-33.6%) |
| Dec 2003 | $9.16 M(-23.1%) | - |
| Dec 2003 | - | $9.16 M(-8.2%) |
| June 2003 | - | $9.98 M |
| Dec 2002 | $11.91 M(-7.3%) | - |
| Dec 2001 | $12.85 M(-22.0%) | - |
| Dec 2000 | $16.47 M(+10.7%) | - |
| Dec 1999 | $14.87 M(+169.4%) | - |
| Dec 1998 | $5.52 M(-27.5%) | - |
| Dec 1997 | $7.61 M(-29.2%) | - |
| Dec 1996 | $10.75 M(+151.1%) | - |
| Dec 1995 | $4.28 M | - |
FAQ
- What is Silence Therapeutics annual working capital?
- What is the all time high annual working capital for Silence Therapeutics?
- What is Silence Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Silence Therapeutics?
- What is Silence Therapeutics quarterly working capital year-on-year change?
What is Silence Therapeutics annual working capital?
The current annual working capital of SLN is $80.58 M
What is the all time high annual working capital for Silence Therapeutics?
Silence Therapeutics all-time high annual working capital is $96.05 M
What is Silence Therapeutics quarterly working capital?
The current quarterly working capital of SLN is $188.15 M
What is the all time high quarterly working capital for Silence Therapeutics?
Silence Therapeutics all-time high quarterly working capital is $211.54 M
What is Silence Therapeutics quarterly working capital year-on-year change?
Over the past year, SLN quarterly working capital has changed by +$107.57 M (+133.51%)